Heart rate dynamics during a treadmill cardiopulmonary exercise test in optimized beta-blocked heart failure patients

Clinics

Volumn 63, Issue 4, 2008, Pages 479-482

  Carvalho, Vitor Oliveira ^a   Guimarães, Guilherme Veiga ^a   Ciolac, Emmanuel Gomes ^a   Bocchi, Edimar Alcides ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Carvedilol; Exercise; Heart failure; Heart rate; Optimization

Indexed keywords

EID: 50449086794     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322008000400011     Document Type: Article

References (11)

1. Working Group on Cardiac Rehabilitation & Exercise Physiology and Working Group on Heart Failure of the European Society of Cardiology. Recommendations for exercise testing in chronic heart failure patients. Eur Heart J. 2001;22:37-45.
2. Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel JP. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation. 1998;98:1184-91.
3. Witte KK, Thackray S, Nikitin NP, Cleland JG, Clark AL. The effects of long-term beta-blockade on the ventilatory responses to exercise in chronic heart failure. Eur. J. Heart Fail. 2005;7:612-617.
4. O'Neill JO, Young JB, Pothier CE, Lauer MS. Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation. 2005;111:2313-18.
5. Task Force of the Italian Working Group on Cardiac Rehabilitation Prevention. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part I: Definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2006;13:150-64.
6. Agarwal AK, Venugopalan P. Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy. Eur J Heart Fail. 2001;3:437-40.
7. Packer M, Coats A, Fowler M, Katus H, Krum H, Mohacsi P et al. Effect of Carvedilol on Survival in Severe Chronic Heart Failure. 2001;334:1651-58.
8. Perini R, Veicsteinas A. Heart rate variability and autonomic activity at rest and during exercise in various physiological conditions. Eur J Appl Physiol. 2003;90:317-25.
9. Kasama S, Toyama T, Hatori T, Sumino H, Kumakura H, Takayama Y, et al. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol. Eur Heart J. 2007;28:989-95.
10. Karavirta L, Tulppo MP, Nyman K, Laaksonen DE, Pullinen T, Laukkanen RT, et al. Estimation of maximal heart rate using the relationship between heart rate variability and exercise intensity in 40-67 years old men. Eur J Appl Physiol. 2008 Jan 11 [Epub ahead of print].
11. Clinton A Brawner, Steven J Keteyian, And Jonathan K Ehrman. The relationship of heart rate reserve to VO[sub2] reserve in patients with heart disease. Medicine and Science in Sports and Exercise. 2002;34:418-22.